GLOW

GLOW is a 70 mg lyophilized research blend of three peptides in one vial: BPC-157, TB-500 and GHK-Cu. Its batch certificate, shown on this page, tests each of the three components separately and reports a quantity and a purity figure for each. The blend is supplied for qualified laboratory research only, and no published study has examined this particular three-part combination.

Research reagent identity

The table gives one block per component. Amounts are the per-component specifications printed on the certificate for lot RRL-6055127-P; identifiers were checked against PubChem.

A note on the name: “TB-500” is used by suppliers both for full-length thymosin beta-4 and for a short synthetic fragment, Ac-LKKTETQ, which corresponds to residues 17–23 of the parent protein.^{22962027, 23084823} The identifiers printed for the TB-500 line on this lot’s certificate are those of the full-length 43-residue peptide.

Research literature

GLOW is a three-component blend of BPC-157, TB-500 (identified on the certificate as full-length thymosin beta-4) and GHK-Cu. Each component has its own primary literature; no published study describes this blend. Primary sources are linked below for researchers who need the original papers. This listing does not summarise study outcomes and makes no claim about any effect, use or benefit of this product, which is supplied as a reference material for in vitro laboratory research only.

References (PubMed): PMID 8298609, PMID 14554208, PMID 21030672, PMID 27847966, PMID 23755725, PMID 40756949, PMID 6940133, PMID 16099219, PMID 10469335, PMID 15565145, PMID 14500546, PMID 7453802, PMID 3169264, PMID 8227353, PMID 42542926

Batch documentation

The certificate card shows batch RRL-6055127-P, purity 99.31%, dated 27 JUN 2026, lab horizonanalytical.com. The purity PDF is a multi-page Horizon Analytical report (received 06/23/2026, analysed 06/27/2026, UPLC/MS) with one page per component: BPC-157 at 99.31%, TB-500 at 99.27% and GHK-Cu at 99.56%. The 99.31% on the card is the BPC-157 line. A separate endotoxin report, lot RRL-6055127-E, tests the blend as a whole and records <0.05 EU/mL.

Match the lot on the vial label to the batch on the card and on each PDF page before using the data. Batch certificates are posted when available, and every posted report is listed in the COA library. The step-by-step guide to verifying a peptide COA explains how to confirm a report with the lab.

Storage and handling

Store unopened vials of the dry blend cold, sealed and protected from light; the blue tint comes from the copper in the GHK-Cu component. Let the vial warm to room temperature before opening. Reconstitution water is a separate item, available as reconstitution solution. For general practice, see peptide storage basics for research labs.

The same three components are also sold as single-compound listings, BPC-157, TB-500 and GHK-Cu, and the blend is available in pen format as the GLOW 70 mg pen.

Frequently asked questions

What does the certificate list as the components of GLOW?

The posted certificate (lot RRL-6055127-P) reports three components: BPC-157 at a 10 mg specification, TB-500 at a 10 mg specification and GHK-Cu at a 50 mg specification, which together make up the 70 mg on this listing. Each component has its own purity line.

Which purity figure is shown on the product card?

The card shows 99.31%, which is the BPC-157 line of the certificate. The same report lists 99.27% for the TB-500 line and 99.56% for the GHK-Cu line, all by UPLC/MS against a >98% specification.

Is the TB-500 in GLOW full-length thymosin beta-4 or the short fragment?

The name TB-500 is used in the market both for full-length thymosin beta-4 and for a 7-residue synthetic fragment (Ac-LKKTETQ). The TB-500 entry on this lot’s certificate prints CAS 77591-33-4, formula C212H350N56O78S and about 4963 g/mol, which are the identifiers of full-length thymosin beta-4.

How is the GLOW vial different from the GLOW pen?

This vial holds the three-component blend as a dry lyophilized powder for the lab to reconstitute. The GLOW 70 mg pen is a separate pen-format listing; check the batch card on whichever listing you order.

For research use only. Not for human or animal consumption, administration, injection, topical use, medical, clinical, veterinary, food, cosmetic, supplement, household, or other personal use. This site does not provide medical advice, and this product is not intended to diagnose, treat, cure, mitigate, or prevent any disease.

These statements have not been evaluated by the Food and Drug Administration. Review the available COA or batch documentation and follow applicable laws, institutional protocols, and safety procedures before handling.

Batch documentation for GLOW is organized by product, selected variant, and available lot when supplied. Review available COA records, purity or quality documentation, and product identifiers before purchase and before any laboratory handling.

If documentation is not displayed for a selected size or lot, contact support before ordering. Documentation is provided for research recordkeeping and product verification only.

Keep this material sealed until controlled laboratory handling. Store and handle only according to the product label, available COA or SDS, institutional SOPs, and applicable laws.

Use appropriate personal protective equipment and restrict access to qualified personnel. This material is not for human or animal consumption, administration, injection, topical use, medical, clinical, veterinary, food, cosmetic, supplement, household, or other personal use. Dispose of waste according to laboratory protocol and local requirements.